Haleon Plc (HLN) - Financial and Strategic SWOT Analysis Review

Haleon Plc (HLN) - Financial and Strategic SWOT Analysis Review


- provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

The profile contains critical company information including:
  • Business description – A detailed description of the company’s operations and business divisions.
  • Corporate strategy – Analyst’s summarization of the company’s business strategy.
  • SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
  • Company history – Progression of key events associated with the company.
  • Major products and services – A list of major products, services and brands of the company.
  • Key competitors – A list of key competitors to the company.
  • Key employees – A list of the key executives of the company.
  • Executive biographies – A brief summary of the executives’ employment history.
  • Key operational heads – A list of personnel heading key departments/functions.
  • Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
  • Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
  • Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.
Highlights

Haleon Plc (Haleon) is a manufacturer of consumer healthcare products. The company’s product range includes over-the-counter (OTC) drugs for respiratory infections, cold and flu, fever, allergy, pain relief, and inflammation, and oral health products such as toothpaste, toothbrushes, and mouthwash. It also offers nasal decongestants, calcium and vitamin-C supplements, and solutions for heartburn, acid indigestion, and gastric discomfort. The company markets its products under Advil, Eno, Tums, Sensodyne, Panadol, Voltaren, Theraflu, Otrivin, Polident, parodontax and Centrum brand names. It has business presence across the Americas, Europe, the Middle East, Africa, and Asia-Pacific. Haleon is headquartered in Weybridge, England, the UK.Haleon Plc Key Recent Developments

Aug 06,2024: Haleon Announces Board Changes
May 01,2024: Haleon PLC Announces Directorate Change
Apr 24,2024: Haleon plc: Appointment of Dawn Allen as Chief Financial Officer
Feb 29,2024: Haleon Reports 2023 Full Year Results

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note:Some sections may be missing if data is unavailable for the company


Section 1 - About the Company
Haleon Plc - Key Facts
Haleon Plc - Key Employees
Haleon Plc - Key Employee Biographies
Haleon Plc - Major Products and Services
Haleon Plc - History
Haleon Plc - Company Statement
Haleon Plc - Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Section 2 – Company Analysis
Company Overview
Haleon Plc - Business Description
Product Category: Digestive Health and Other
Overview
Performance
Product Category: Oral Health
Overview
Performance
Product Category: Pain Relief
Overview
Performance
Product Category: Respiratory Health
Overview
Performance
Product Category: Vitamins, Minerals and Supplements
Overview
Performance
Geographical Segment: APAC
Target Markets
Performance
Geographical Segment: EMEA and LatAm
Target Markets
Performance
Geographical Segment: North America
Target Markets
Performance
R&D Overview
Haleon Plc - Corporate Strategy
Haleon Plc - SWOT Analysis
SWOT Analysis - Overview
Haleon Plc - Strengths
Haleon Plc - Weaknesses
Haleon Plc - Opportunities
Haleon Plc - Threats
Haleon Plc - Key Competitors
Section 3 – Company Financial Ratios
Financial Ratios - Capital Market Ratios
Financial Ratios - Annual Ratios
Performance Chart
Financial Performance
Financial Ratios - Interim Ratios
Financial Ratios - Ratio Charts
Haleon Plc, Recent Deals Summary
Section 4 – Company’s Recent Developments
Aug 06, 2024: Haleon Announces Board Changes
May 01, 2024: Haleon PLC Announces Directorate Change
Apr 24, 2024: Haleon plc: Appointment of Dawn Allen as Chief Financial Officer
Feb 29, 2024: Haleon Reports 2023 Full Year Results
Jan 24, 2024: Haleon Issues Voluntary Nationwide Recall of Robitussin Honey CF Max Day Adult and Robitussin Honey CF Max Nighttime Adult Products Due to Microbial Contamination
Aug 02, 2023: Haleon Announces 2023 Half-Year Results
Apr 20, 2023: Haleon PLC Results of Haleon 2023 Annual General Meeting
Mar 02, 2023: Haleon Reports 2022 Full year results
Jan 31, 2023: Haleon Announces Board changes
Section 5 – Appendix
Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer
List of Tables
Haleon Plc, Key Facts
Haleon Plc, Key Employees
Haleon Plc, Key Employee Biographies
Haleon Plc, Major Products and Services
Haleon Plc, History
Haleon Plc, Other Locations
Haleon Plc, Subsidiaries
Haleon Plc, Key Competitors
Haleon Plc, Ratios based on current share price
Haleon Plc, Annual Ratios
Haleon Plc, Annual Ratios (Cont...1)
Haleon Plc, Annual Ratios (Cont...2)
Haleon Plc, Interim Ratios
Haleon Plc, Recent Deals Summary
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios
List of Figures
Haleon Plc, Performance Chart (2019 - 2023)
Haleon Plc, Ratio Charts

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings